LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers.

Abstract

Long non-coding RNAs (lncRNAs) are a class of functional RNA molecules that do not encode proteins and are composed of more than 200 nucleotides. LncRNAs play important roles in epigenetic and gene expression regulation. The oncogenic lncRNA GACAT3 was recently discovered to be dysregulated in many tumors. Aberrant expression of GACAT3 contributes to clinical characteristics and regulates multiple oncogenic processes. The association of GACAT3 with a variety of tumors makes it a promising biomarker for diagnosis, prognosis, and targeted therapy. In this review, we integrate the current understanding of the pathological features, biological functions, and molecular mechanisms of GACAT3 in cancer. Additionally, we provide insight into the utility of GACAT3 as an effective diagnostic and prognostic marker for specific tumors, which offers novel opportunities for targeted therapeutic intervention.

• Authors: Xin Yuan, Zihui Dong, Shen Shen
• Journal: Frontiers in cell and developmental biology (Front Cell Dev Biol) Vol. 10 Pg. 785030 ( 2022) ISSN: 2296-634X [Print] Switzerland
• PMID: 35127682 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2022 Yuan, Dong and Shen.